SFSandra A. C. Figueiredo

Sandra A. C. Figueiredo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandra A. C. Figueiredo has a total of 65 co-authors. Here are the top co-authors by number of shared publications:

  • Pedro Nuno Leão

    Interdisciplinary Centre of Marine and Environmental Research (CIIMAR/CIMAR), University of Porto

    9 shared publications
  • Jorge António Ribeiro Salvador

    Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal

    5 shared publications
  • Kathleen Abt

    CIIMAR - University of Porto

    5 shared publications
  • Gabriela Moreira

    Interdisciplinary Centre of Marine and Environmental Research (CIIMAR/CIMAR) University of Porto Avenida General Norton de Matos, s/n 4450-208 Matosinhos Portugal

    4 shared publications
  • Teresa P. Martins

    Interdisciplinary Centre of Marine and Environmental Research (CIIMAR/CIMAR) University of Porto Avenida General Norton de Matos, s/n 4450-208 Matosinhos Portugal

    4 shared publications
  • João P. A. Reis

    Interdisciplinary Centre of Marine and Environmental Research (CIIMAR/CIMAR), University of Porto, Avenida General Norton de Matos, s/n, 4450-208, Matosinhos, Portugal

    3 shared publications

Latest Publications

  • Open Access

    Activation-independent capture of free fatty acids at the bacterial cell envelope by BrtB

    by Amaranta Kahn, Cristina I.F. Sousa, João P. A. Reis, David A. Russo, Adriana Rego, Ricardo J.C.V Queirós, Marine Cuau, Julie A. Z. Zedler, Sandra A.C. Figueiredo, Paulo Oliveira, et al.

    Fatty acids (FAs) are key metabolites in living organisms, shaping membrane architecture and helping cellular acclimatization to changing conditions. Bacteria synthesize FA de novo but can also reclaim them from membrane lipids or uptake them from the environment, usually converting free fatty acids (FFAs) into activated FAs that can then be further metabolized. In cyanobacteria, it is the acyl-acyl carrier protein synthetase (Aas) that activates exogenous FFAs. Yet, the cyanobacterial enzyme BrtB was recently shown to esterify, in vitro , FFAs directly onto abundant chlorinated glycolipids (bartolosides), generating bartoloside fatty acid esters (B-FAs). Whether this chemistry operates in vivo , where it occurs, and what its implications are for cell physiology has remained unclear. Here we show that in the cyanobacterium Synechocystis salina LEGE 06099, BrtB captures FFAs at the cell envelope without prior activation to generate B-FAs. We found that supplemented FFAs were converted into B-FAs within minutes. Strikingly, this response occurred with minimal changes in gene expression and little alteration of the extracellular proteome, consistent with a pathway already in place. Additionally, we observed that B-FAs can further be hydrolyzed into hydroxybartolosides – the levels of the latter metabolites increase in response to FA supply, suggesting a transient sequestration of FFA. Our results demonstrate that activation of FFA is not the only route to their cellular incorporation and identify a specialized-metabolite pathway that captures exogenous FFAs at the cyanobacterial cell envelope.

  • Open Access

    A Wagner-Meerwein-like rearrangement shapes the structures of the fischerazoles, cyanobacterial polychlorinated lipopeptides

    by Pedro Leao, Sandra Figueiredo, Kathleen Abt, Konrad Viehrig, Peter Jervis, Teresa Martins, Inaki Lacomba, Daniele Castagnolo

    The discovery of structurally unusual natural products inspires both the search for novel enzymatic transfor-mations and for new synthetic strategies. Here, we employ stable isotope-labeled precursor feeding and metabolomics to reveal highly unusual cyanobacterial lipopeptides – fischerazoles A-C. These metabolites con-tain a polychlorinated fatty acyl-derived moiety with a vinyl branch and an N-methylated carboxamide-thiazole terminus. Most strikingly, stable-isotope-labeled precursor supplementation showed that during fischerazole biosynthesis, a linear, hexadecanoic acid-derived intermediate is processed to yield the ultimately branched alkyl moiety. The branched-out carbon becomes part of the vinyl group together with an S-adenosyl methionine (SAM)-derived carbon. A polyketide synthase/non-ribosomal peptide synthetase (PKS/NRPS) biosynthetic gene cluster (BGC) associated with the fischerazoles was identified. In vitro assays revealed that the SAM depend-ent methyltranfesrae FshF catalyzes the alkyl chain rearrangement and concomitant vinyl group formation of an ACP-tethered unsaturated fatty acid. FshF-like enzymes, which are related to the well-characterized cyclo-propane fatty acid synthases (CFASs) can thus be explored for alkyl chain functionalization.

  • A class of benzofuranoindoline-bearing heptacyclic fungal RiPPs with anticancer activities

    by Qiuyue Nie, Fanglong Zhao, Xuerong Yu, Mithun C. Madhusudhanan, Caleb Chang, Siting Li, Sandipan Roy Chowdhury, Bryce Kille, Andy Xu, Rory Sharkey, et al.

    Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a promising source of new pharmaceuticals, yet the therapeutic potential of fungal RiPPs remains largely underexplored. Here we report asperigimycins as a distinct class of fungal RiPPs, featuring a unique heptacyclic scaffold consisting of a benzofuranoindoline core and three additional macrocycles, primarily assembled by six distinct fungi-specific DUF3328 oxidases. Inspired by the enhancement of anticancer activity through the N-terminal pyroglutamate in naturally occurring asperigimycins C and D, we chemically modify the inactive asperigimycin B with a series of lipid substitutions at its N-terminus. A derivative with a C-11 linear fatty acid, 2-L6, achieves nanomolar anticancer potency comparable to that of clinically approved antileukemia drugs. High-throughput CRISPR screening identifies the SLC46A3 transporter as a critical factor mediating 2-L6 cellular uptake into human cells. Our findings highlight the promise of engineering asperigimycins as therapeutic leads for cancer treatment.


  • Open Access

    Discovery of Cyanobacterial Natural Products Containing Fatty Acid Residues**

    by Sandra A. C. Figueiredo, Marco Preto, Gabriela Moreira, Teresa P. Martins, Kathleen Abt, André Melo, Vitor M. Vasconcelos, Pedro N. Leão

    In recent years, extensive sequencing and annotation of bacterial genomes has revealed an unexpectedly large number of secondary metabolite biosynthetic gene clusters whose products are yet to be discovered. For example, cyanobacterial genomes contain a variety of gene clusters that likely incorporate fatty acid derived moieties, but for most cases we lack the knowledge and tools to effectively predict or detect the encoded natural products. Here, we exploit the apparent absence of a functional β‐oxidation pathway in cyanobacteria to achieve efficient stable‐isotope‐labeling of their fatty acid derived lipidome. We show that supplementation of cyanobacterial cultures with deuterated fatty acids can be used to easily detect natural product signatures in individual strains. The utility of this strategy is demonstrated in two cultured cyanobacteria by uncovering analogues of the multidrug‐resistance reverting hapalosin, and novel, cytotoxic, lactylate‐nocuolin A hybrids—the nocuolactylates.


  • Open Access

    Discovery of Cyanobacterial Natural Products Containing Fatty Acid Residues**

    by Sandra A. C. Figueiredo, Marco Preto, Gabriela Moreira, Teresa P. Martins, Kathleen Abt, André Melo, Vitor M. Vasconcelos, Pedro N. Leão

    In recent years, extensive sequencing and annotation of bacterial genomes has revealed an unexpectedly large number of secondary metabolite biosynthetic gene clusters whose products are yet to be discovered. For example, cyanobacterial genomes contain a variety of gene clusters that likely incorporate fatty acid derived moieties, but for most cases we lack the knowledge and tools to effectively predict or detect the encoded natural products. Here, we exploit the apparent absence of a functional β‐oxidation pathway in cyanobacteria to achieve efficient stable‐isotope‐labeling of their fatty acid derived lipidome. We show that supplementation of cyanobacterial cultures with deuterated fatty acids can be used to easily detect natural product signatures in individual strains. The utility of this strategy is demonstrated in two cultured cyanobacteria by uncovering analogues of the multidrug‐resistance reverting hapalosin, and novel, cytotoxic, lactylate‐nocuolin A hybrids—the nocuolactylates.


  • Open Access

    Discovery of Cyanobacterial Natural Products Containing Fatty Acid Residues

    by Sandra A. C. Figueiredo, Marco Preto, Gabriela Moreira, Teresa P. Martins, Kathleen Abt, André Melo, Vitor M. Vasconcelos, Pedro Leao

    Natural products have an important role in several human activities, most notably as sources of new drugs. In recent years, massive sequencing and annotation of bacterial genomes has revealed an unexpectedly large number of secondary metabolite biosynthetic gene clusters whose products are yet to be discovered. For example, cyanobacterial genomes contain a large number of gene clusters that likely incorporate fatty acid-derived moieties, but for most cases we lack the knowledge and tools to effectively predict or detect the encoded natural products. Here, we exploit the apparent lack of a functional beta-oxidation pathway in cyanobacteria to achieve efficient stable-isotope labeling of their fatty acid-derived lipidome. We show that supplementation of cyanobacterial cultures with deuterated fatty acids can be used to easily detect natural product signatures in individual strains. The utility of this strategy is demonstrated in two cultured cyanobacteria by uncovering analogues of the multidrug-resistance reverting hapalosin, and novel, cytotoxic, lactylate-nocuolin A hybrids – the nocuolactylates.

  • Open Access

    Discovery of Cyanobacterial Natural Products Containing Fatty Acid Residues

    by Sandra A. C. Figueiredo, Marco Preto, Gabriela Moreira, Teresa P. Martins, Kathleen Abt, André Melo, Vitor M. Vasconcelos, Pedro Leao

    Natural products have an important role in several human activities, most notably as sources of new drugs. In recent years, massive sequencing and annotation of bacterial genomes has revealed an unexpectedly large number of secondary metabolite biosynthetic gene clusters whose products are yet to be discovered. For example, cyanobacterial genomes contain a large number of gene clusters that likely incorporate fatty acid-derived moieties, but for most cases we lack the knowledge and tools to effectively predict or detect the encoded natural products. Here, we exploit the apparent lack of a functional beta-oxidation pathway in cyanobacteria to achieve efficient stable-isotope labeling of their fatty acid-derived lipidome. We show that supplementation of cyanobacterial cultures with deuterated fatty acids can be used to easily detect natural product signatures in individual strains. The utility of this strategy is demonstrated in two cultured cyanobacteria by uncovering analogues of the multidrug-resistance reverting hapalosin, and novel, cytotoxic, lactylate-nocuolin A hybrids – the nocuolactylates.

  • Open Access

    BrtB is an O-alkylating enzyme that generates fatty acid-bartoloside esters

    by João P. A. Reis, Sandra A. C. Figueiredo, Maria Lígia Sousa, Pedro N. Leão

    Esterification reactions are central to many aspects of industrial and biological chemistry. The formation of carboxyesters typically occurs through nucleophilic attack of an alcohol onto the carboxylate carbon. Under certain conditions employed in organic synthesis, the carboxylate nucleophile can be alkylated to generate esters from alkyl halides, but this reaction has only been observed transiently in enzymatic chemistry. Here, we report a carboxylate alkylating enzyme – BrtB – that catalyzes O-C bond formation between free fatty acids of varying chain length and the secondary alkyl halide moieties found in the bartolosides. Guided by this reactivity, we uncovered a variety of natural fatty acid-bartoloside esters, previously unrecognized products of the bartoloside biosynthetic gene cluster.


  • Open Access

    BrtB Is a Novel O-Alkylating Enzyme That Generates Fatty Acid-Bartoloside Esters

    by João P. A. Reis, Sandra A. C. Figueiredo, Pedro Leao

    Esterification reactions are central to many aspects of industrial and biological chemistry. The formation of carboxyesters typically occurs through nucleophilic attack of an alcohol onto the carboxylate carbon. Under certain conditions employed in organic synthesis, the carboxylate nucleophile can be alkylated to generate esters from alkyl halides, but this reaction has only been observed transiently in enzymatic chemistry. Here, we report a new carboxylate alkylating enzyme – BrtB – that catalyzes O-C bond formation between free fatty acids and the secondary alkyl halide moieties found in the bartolosides. Guided by this novel reactivity, we uncovered a variety of natural fatty acid-bartoloside esters, the likely end-products of bartoloside biosynthetic gene clusters.

  • Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment

    by Jorge A.R. Salvador, Ana S. Leal, Ana S. Valdeira, Bruno M.F. Gonçalves, Daniela P.S. Alho, Sandra A.C. Figueiredo, Samuel M. Silvestre, Vanessa I.S. Mendes